I sincerely respect and appreciate all the DD you bring to
I sincerely respect and appreciate all the DD you bring to this forum - for that thank you.
I agree that one can't expect the company to manage the day-to-day price fluctuations of its share price, but the share price is down by over 91% since February. At what point should management be held accountable for managing that kind of drop? I've heard over and over again - the price should have never ran that high - I understand that, but it also shouldn't be struggling to maintain in the $0.30's range. Day after day after day it's red and red again - it's time investors demand accountability from management.
Struggling to maintain a share price of $0.32 - that's crazy.... one side in this ongoing game is terribly wrong - the question is which one is wrong. Will this prove to be one of the largest P&Ds of 2017 or will it prove to be a shining star? I'm hoping the latter but day-to-day the other side is winning the debate.
Back in Jan, Feb and even in March after the first significant drop I was so excited to be invested in this company - now I've lost a lot of faith in it.
Someone on the other board summed it up nicely - OWCP has a crisis of trust on its hands. Problem they face now is even if this reverses in a positive direction many will sell as soon as they're even because they feel that they were lied to by the company. Add that to the shorters and day-traders there is tough sledding ahead without major breakout news.
Trust has been broken yet management continues to do nothing to address the situation. Something has gone horribly wrong, and I'm tired of giving them a pass for their poor communication skills. We shouldn't be debating among ourselves what so many things mean - the company should be controlling its narrative.
We're debating - does OWCP have an agreement with CFN or do they not? No PRs of any significance have released so what in the hell did they pay for? Are there issues with the ongoing studies or not? What is the status? Are they in process of applying to list on the Canadian exchange or is that just a future goal? What is the status of selling any product, anywhere?
I hope I'm pleasantly surprised by the 10Q due on the 15th that has answers to many of the open questions but my gut is telling me that it will probably be yet another release of "trust us we're doing great things" but "we can't share any specifics until some unknown future date" which no one knows whether that means three months, six months or years away.
4
1
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A New Serving in Spanish Fork Chicken Salad Chick is taking another bite out of the Utah market with the opening of its second location in Spanish Fork. On deck for a November 17 debut, this fast-casual chain is serving up not just chicken salad, but a hefty dose of Southern hospitality and promotional giveaways to boot. The big hook? Be among the first 100 patrons and...
Continue Reading
There's a badge of honor in the investment world that's not about the dollars and cents pouring in—it's about having founders trust you to take care of their business babies. Good Springs Capital just snagged one by being named to Inc.'s 2026 Founder-Friendly Investors list. Now, if you're thinking this is just some fancy accolade, let's chew over the real nuggets here....
Continue Reading
Change in Flight: Bird-X Eyes Strategic Growth Well, here's one that might spread its wings wide. Emanuel Doolittle has joined Bird-X, Inc. as Director of Sales and Business Development. Now, let's not beat around the bush — Bird-X isn't a name you'd see thrown around daily stock talks, but it's stirring up interest in the pest control sector without question. Why...
Continue Reading
An Unyielding Growth Trajectory Hagerty, Inc. just unveiled its behemoth third quarter results for 2026 and they're nothing if not eye-popping. With a whopping 18% increase in written premium year-over-year to a towering $1,099 million, there's no mistaking Hagerty’s robust growth trajectory. And that's just one piece of the puzzle—earned premiums rocketed up by 42%...
Continue Reading
Pet Food Revolution? Wet Noses Takes the PLMA Stage Okay, listen up, pet lovers and industry folks alike—seems like Wet Noses, that Washington-based veteran in the dog treat game, is shaking up the pet food world. After cruising through the pet aisle for almost three decades, they're making a splash at the PLMA 2026. Why should we care? Well, they’re pushing this...
Continue Reading
Novartis Drops BioArctic Like a Hot Potato Well, folks, it looks like Novartis has decided to pack up its bags and hightail it out of its collaboration with BioArctic AB. This ain't just any small piece of news—it's got ramifications that have folks in the biotech and healthcare sector scratching their heads and, probably, feeling a mixture of apprehension and...
Continue Reading
Grappling with Numbers: Truecaller's Q3 2026 Results A glance at Truecaller's latest report tells us they're banking on a strategic recovery.AOver their recent interim report covering January to September 2026, they disclose a modest 1% decrease in net sales reaching SEK 464 million. Now, if you scoop away the currency fluctuations, net sales climb by a soft 3% from Q2....
Continue Reading
Singapore's Bold Step into Precision Medicine When it comes to revolutionizing healthcare, Singapore isn't content to sit on the sidelines. They've just thrown a serious hat into the ring with the SG-INSIGHT study, a cornerstone of their National Precision Medicine programme. And Illumina, Inc. (NASDAQ:ILMN) is right there in it, gearing up to sequence the genomes of...
Continue Reading
Shaking Up the Leadership Roster The folks over at Elron Ventures are making some big moves, shifting the chess pieces on their leadership board in a bid to bolster their investment and M&A strategy. They're bringing in fresh blood and seasoned vets alike to navigate the rocky waters of Defense Tech, Deep Tech, Cybersecurity, and AI. You reckon they're onto something,...
Continue Reading
Finding Solace in Change: The Power of Stepping Away Grieving a lost child. It’s a trip to hell and back, and for many families, the journey feels endless. The press of everyday life—bills, jobs, commutes—offers no mercy. At times, stepping out of the blur might be the prime move toward healing, and that's where restorative getaways step in. Escaping the Everyday...
Continue Reading
Top 5 Most Recently Viewed Articles
Insights from Q1 2025 Insurance Labor Market Webinar Chicago has become a hub for discussions about the future of the insurance industry, especially with the forthcoming webinar highlighting the results of the Q1 2025 Insurance Labor Market Study. This semi-annual study, spearheaded by The Jacobson Group, a notable leader in providing talent within the insurance sector,...
Continue Reading
Organic Growth Amid Economic Challenges Essity's recent quarterly report underscores the company's resilience in the face of a tough economic landscape. Highlighting an organic sales growth of 1.9%, the company's diverse portfolio of hygiene and health products is proving to be a strong foundation during uncertain times. Quarterly Performance Overview The report for the...
Continue Reading
Equifax Reports Impressive Q2 Financial Results Equifax Inc. (NYSE: EFX) recently delivered its financial outcomes for the latest quarter, demonstrating remarkable performance despite challenging market conditions. The company reported an impressive revenue of $1.537 billion for the second quarter of 2025, reflecting a notable growth rate of 7% on a reported basis and 8%...
Continue Reading
JetBlue Airways Reports Wider Loss JetBlue Airways Corp. (NASDAQ: JBLU) announced a net loss of $143 million, translating to a loss of 39 cents per diluted share. This is a significant drop from last year's loss of $60 million, or 17 cents per share, indicating challenges in the current operational climate. Adjusted Earnings and Revenue Performance Despite the reported...
Continue Reading
Understanding the Nextracker Class Action Lawsuit The recent developments regarding Nextracker Inc. have raised significant concerns among investors, particularly those who have suffered substantial financial losses. Kahn Swick & Foti, LLC (KSF), led by former Louisiana Attorney General Charles C. Foti, Jr., is urging affected shareholders to take action before the...
Continue Reading